Loading viewer...
investor_presentation
Format: PDF investor_presentation
Terumo Blood and Cell Technologies outlines its 5-year growth strategy with a 10-year vision, celebrating the company's 100th founding anniversary. The strategy targets near double-digit revenue growth and adjusted operating profit margins beyond 20% under the GS26 financial aspiration. Terumo aims to provide innovative solutions in blood and cell technologies to improve patient outcomes globally.
investor_presentation
16 Pages
investor_presentation
32 Pages
Lithia Motors